This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0962280208092347v1 18/1/67    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Arbogast, P. G. Articles by Ray, W. A. Search for Related Content PubMed PubMed Citation Articles by Arbogast, P. G. Articles by Ray, W. A. Social Bookmarking                         What's this?

Use of disease risk scores in pharmacoepidemiologicstudies

¹ Department of Biostatistics, Vanderbilt University, Nashville, TN, USA
² Department of Preventive Medicine, Vanderbilt University, Nashville, TN and Geriatric Research, Education and Clinical Center, Nashville Veteran's Administration Medical Center, Nashville, TN 37232, USA

^* To whom correspondence should be addressed.

	Abstract

Automated databases are increasingly used in pharmacoepidemiologic studies. These databases include records of prescribed medications and encounters with medical care providers from which one can construct very detailed surrogate measures for both drug exposure and covariates that are potential confounders. Often it is possible to track day-by-day changes in these variables. However, while this information is often critical for study success, its volume can pose challenges for statistical analysis. One common approach is the use of propensity scores. An alternative approach is to construct a disease risk score. This is analogous to the propensity score in that it calculates a summary measure from the covariates. However, the disease risk score estimates the probability or rate of disease occurrence conditional on being unexposed. The association between exposure and disease is then estimated adjusting for the disease risk score in place of the individual covariates. This review describes the use of disease risk scores in pharmacoepidemiologic studies, and includes a brief discussion of their history, a more detailed description of their construction and use, a summary of simulation studies comparing their performance vis-á-vis traditional models, a comparison of their utility with that of propensity scores, and some further topics for future research.

First published on June 18, 2008, doi:10.1177/0962280208092347

Statistical Methods in Medical Research 2009;18:67.

A more recent version of this article appeared on February 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?